Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001205347 | SCV001376598 | likely benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002561181 | SCV003754764 | uncertain significance | Inborn genetic diseases | 2022-07-21 | criteria provided, single submitter | clinical testing | The c.3143A>G (p.Y1048C) alteration is located in exon 25 (coding exon 25) of the CACNA1S gene. This alteration results from a A to G substitution at nucleotide position 3143, causing the tyrosine (Y) at amino acid position 1048 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |